On the association between valproate and polycystic ovary syndrome: a response and an alternative view.
Isojärvi
J I
JI
Department of Neurology, University of Oulu, Finland. jouko.isojarvi@oulu.fi
Taubøll
E
E
Tapanainen
J S
JS
Pakarinen
A J
AJ
Laatikainen
T J
TJ
Knip
M
M
Myllylä
V V
VV
D000293:Adolescent; D000328:Adult; D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D015897:Comorbidity; D004827:Epilepsy / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D005298:Fertility / Q000502:physiology; D006801:Humans; D017588:Hyperandrogenism / Q000139:chemically induced / Q000453:epidemiology; D011085:Polycystic Ovary Syndrome / Q000139:chemically induced* / Q000453:epidemiology; D051381:Rats; D012107:Research Design / Q000592:standards; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D000927:Anticonvulsants; D014635:Valproic Acid